Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-3803 vs Ovidrel for Final Follicular Maturation in ART
NCT01718119Phase 3Completed
- Sponsor
- Dong-A Pharmaceutical
- Start
- Feb 2012
- Primary completion
- Feb 2013
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 3 trial of DA-3803 in infertility, sponsored by Dong-A Pharmaceutical. Started Feb 2012; status: completed.
02
Drugs
DA-3803
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01718119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01718119.